Centennial Surgical [CSURGSU] vs Dr Agarwal's Health [AGARWALEYE] Detailed Stock Comparison

Centennial Surgical
BSE
Loading...

Dr Agarwal's Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Centennial Surgical wins in 6 metrics, Dr Agarwal's Health wins in 10 metrics, with 0 ties. Dr Agarwal's Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Centennial Surgical | Dr Agarwal's Health | Better |
---|---|---|---|
P/E Ratio (TTM) | 2,482.50 | 625.56 | Dr Agarwal's Health |
Price-to-Book Ratio | 1.82 | 7.45 | Centennial Surgical |
Debt-to-Equity Ratio | 108.97 | 49.87 | Dr Agarwal's Health |
EV/EBITDA | 16.07 | 31.57 | Centennial Surgical |
Profit Margin (TTM) | -2.74% | 4.88% | Dr Agarwal's Health |
Operating Margin (TTM) | 6.05% | 15.34% | Dr Agarwal's Health |
EBITDA Margin (TTM) | 6.05% | 15.34% | Dr Agarwal's Health |
Return on Equity | -4.65% | 6.61% | Dr Agarwal's Health |
Return on Assets (TTM) | 1.53% | 4.39% | Dr Agarwal's Health |
Free Cash Flow (TTM) | $56.05M | $394.30M | Dr Agarwal's Health |
1-Year Return | 40.78% | 10.98% | Centennial Surgical |
Price-to-Sales Ratio (TTM) | 1.04 | 8.21 | Centennial Surgical |
Enterprise Value | $891.12M | $144.09B | Dr Agarwal's Health |
EV/Revenue Ratio | 1.67 | 8.42 | Centennial Surgical |
Gross Profit Margin (TTM) | 73.40% | N/A | N/A |
Revenue per Share (TTM) | $147 | $57 | Centennial Surgical |
Earnings per Share (Diluted) | $-4.01 | $0.71 | Dr Agarwal's Health |
Beta (Stock Volatility) | 0.49 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Centennial Surgical vs Dr Agarwal's Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Centennial Surgical | 1.29% | 5.12% | -1.90% | 24.05% | 14.39% | 13.97% |
Dr Agarwal's Health | 0.76% | -2.02% | 4.44% | 21.23% | 9.67% | 11.09% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Centennial Surgical | 40.78% | 192.45% | 272.15% | 214.08% | 7,351.92% | 14,661.90% |
Dr Agarwal's Health | 10.98% | 10.98% | 10.98% | 10.98% | 10.98% | 10.98% |
Performance & Financial Health Analysis: Centennial Surgical vs Dr Agarwal's Health
Metric | CSURGSU | AGARWALEYE |
---|---|---|
Market Information | ||
Market Cap | ₹558.19M | ₹140.42B |
Market Cap Category | Small cap | Mid cap |
10 Day Avg. Volume | 134 | 268,372 |
90 Day Avg. Volume | 180 | 284,346 |
Last Close | ₹157.00 | ₹449.60 |
52 Week Range | ₹82.15 - ₹169.50 | ₹327.00 - ₹494.50 |
% from 52W High | -7.37% | -9.08% |
All-Time High | ₹169.50 (Dec 16, 2024) | ₹494.50 (Jul 30, 2025) |
% from All-Time High | -7.37% | -9.08% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.10% | 0.32% |
Quarterly Earnings Growth | 0.10% | -0.16% |
Financial Health | ||
Profit Margin (TTM) | -0.03% | 0.05% |
Operating Margin (TTM) | 0.06% | 0.15% |
Return on Equity (TTM) | -0.05% | 0.07% |
Debt to Equity (MRQ) | 108.97 | 49.87 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹84.30 | ₹59.60 |
Cash per Share (MRQ) | ₹0.60 | ₹16.66 |
Operating Cash Flow (TTM) | ₹170.74M | ₹3.60B |
Levered Free Cash Flow (TTM) | ₹-42,696,752 | ₹-474,997,504 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Centennial Surgical vs Dr Agarwal's Health
Metric | CSURGSU | AGARWALEYE |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 2,482.50 | 625.56 |
Forward P/E | N/A | 83.41 |
PEG Ratio | N/A | N/A |
Price to Sales (TTM) | 1.04 | 8.21 |
Price to Book (MRQ) | 1.82 | 7.45 |
Market Capitalization | ||
Market Capitalization | ₹558.19M | ₹140.42B |
Enterprise Value | ₹891.12M | ₹144.09B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.67 | 8.42 |
Enterprise to EBITDA | 16.07 | 31.57 |
Risk & Other Metrics | ||
Beta | 0.49 | N/A |
Book Value per Share (MRQ) | ₹84.30 | ₹59.60 |
Financial Statements Comparison: Centennial Surgical vs Dr Agarwal's Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CSURGSU | AGARWALEYE |
---|---|---|
Revenue/Sales | ₹133.08M | N/A |
Cost of Goods Sold | ₹35.40M | N/A |
Gross Profit | ₹97.68M | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹8.05M | N/A |
EBITDA | ₹21.17M | N/A |
Pre-Tax Income | ₹-13.38M | N/A |
Income Tax | ₹-1.54M | N/A |
Net Income (Profit) | ₹-11.84M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CSURGSU | AGARWALEYE |
---|---|---|
Cash & Equivalents | ₹2.20M | ₹1.04B |
Total Current Assets | ₹629.64M | ₹7.94B |
Total Current Liabilities | ₹318.30M | ₹4.78B |
Long-Term Debt | N/A | ₹8.08B |
Total Shareholders Equity | ₹307.55M | ₹19.27B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹199.83M | ₹13.40B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CSURGSU | AGARWALEYE |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | CSURGSU | AGARWALEYE |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 134 | 268,372 |
Average Daily Volume (90 Day) | 180 | 284,346 |
Shares Outstanding | 3.65M | 315.88M |
Float Shares | 615,942 | N/A |
% Held by Insiders | 0.81% | 0.76% |
% Held by Institutions | 0.00% | 0.16% |
Dividend Analysis & Yield Comparison: Centennial Surgical vs Dr Agarwal's Health
Metric | CSURGSU | AGARWALEYE |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |